Skip to main content
. Author manuscript; available in PMC: 2018 Feb 9.
Published in final edited form as: Mol Cancer Ther. 2016 Aug 15;15(11):2598–2608. doi: 10.1158/1535-7163.MCT-16-0106

Figure 6. (1b) does not activate AKT.

Figure 6

Analysis of lysates from (A) MDA-MB-231 and (B) HDQ-P1 cells treated with vehicle, trametinib (1 μM) or (1b) (25 μM) for 2h. Bar = separate gels.